mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for NANP
Gene summary
Basic gene Info.Gene symbolNANP
Gene nameN-acetylneuraminic acid phosphatase
SynonymsC20orf147|HDHD4|dJ694B14.3
CytomapUCSC genome browser: 20p11.1
Type of geneprotein-coding
RefGenesNM_152667.2,
DescriptionN-acylneuraminate-9-phosphataseNeu5Ac-9-Pasehaloacid dehalogenase-like hydrolase domain containing 4haloacid dehalogenase-like hydrolase domain-containing protein 4
Modification date20141207
dbXrefs MIM : 610763
HGNC : HGNC
Ensembl : ENSG00000170191
HPRD : 17097
Vega : OTTHUMG00000032132
ProteinUniProt: Q8TBE9
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_NANP
BioGPS: 140838
PathwayNCI Pathway Interaction Database: NANP
KEGG: NANP
REACTOME: NANP
Pathway Commons: NANP
ContextiHOP: NANP
ligand binding site mutation search in PubMed: NANP
UCL Cancer Institute: NANP
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0016311dephosphorylation16237198
GO:0046380N-acetylneuraminate biosynthetic process16237198


Top
Ligand binding site mutations for NANP
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
N132D134HLUAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for NANP
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
N132D134H-1.1846153
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for NANP from PDB

Top
Differential gene expression and gene-gene network for NANP
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of NANP and the right PPI network was created from samples without mutations in the LBS of NANP. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for NANP
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for NANP
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of NANP go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
PO4PHOSPHATE ION4knvAN132
PO4PHOSPHATE ION4knvBN132


Top
Conservation information for LBS of NANP
Multiple alignments for Q8TBE9 in multiple species
LBSAA sequence# speciesSpecies
D12RAVFFDLDNTL3Homo sapiens, Mus musculus, Rattus norvegicus
D14VFFDLDNTLID3Homo sapiens, Mus musculus, Rattus norvegicus
D189CVMVGDTLETD3Homo sapiens, Mus musculus, Rattus norvegicus
D194DTLETDIQGGL3Homo sapiens, Mus musculus, Rattus norvegicus
K164EQKEEKPAPSI2Mus musculus, Rattus norvegicus
K164EQREEKPAPSI1Homo sapiens
L13AVFFDLDNTLI3Homo sapiens, Mus musculus, Rattus norvegicus
N132LLLLTNGDRQT3Homo sapiens, Mus musculus, Rattus norvegicus
N15FFDLDNTLIDT3Homo sapiens, Mus musculus, Rattus norvegicus
T131RLLLLTNGDRQ3Homo sapiens, Mus musculus, Rattus norvegicus
T190VMVGDTLETDI3Homo sapiens, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas